RHYTHMS (Eurostars Project)
Not Specified
ResearchActive
Key Facts
About Stemmatters
Stemmatters is a private, revenue-generating CDMO based in Guimarães, Portugal, offering end-to-end contract development and cGMP manufacturing solutions for regenerative medicine products. It operates as a one-stop shop, providing services in contract development, analytical testing, formulation development, and manufacturing for cell therapies, including iPSC-derived products and CAR-T cells. The company is actively engaged in collaborative R&D projects and partnerships, positioning itself as a key European player in the advanced therapy CDMO landscape.
View full company profileOther Not Specified Drugs
| Drug | Company | Phase |
|---|---|---|
| FL116 | Forlong Biotechnology | Not specified |
| FL117 | Forlong Biotechnology | Not specified |
| FL118 | Forlong Biotechnology | Not specified |
| FL301 | Forlong Biotechnology | Not specified |
| JSKN016 | AlphaMab Oncology | Phase 1 |
| JSKN033 | AlphaMab Oncology | Phase 1 |
| JSKN022 | AlphaMab Oncology | Phase 1 |
| JSKN027 | AlphaMab Oncology | Phase 1 |
| KN019 | AlphaMab Oncology | Phase 1 |
| New TCM Formulations | China SXT Pharmaceuticals | Research / Pre-clinical |
| Long-acting Leronlimab | CytoDyn | Preclinical |
| SR2162 | SIMR (Australia) Biotech | IND Approved |